Gingival Inflammation Modulates NLRP3 Inflammasome Signalling in Peripheral Blood Mononuclear Cells of PCOS Patients: A Case-Control Study
Polycystic ovary syndrome (PCOS) is a complex condition associated with chronic inflammation and oxidative stress and is often linked to periodontal diseases. This study aimed to determine whether gingivitis modulates the NLRP3 inflammasome in peripheral blood mononuclear cells (PBMCs) from women with PCOS. Following a case-control design, 104 women were divided into three groups: controls (n = 36), PCOS without gingivitis (PCOS, n = 44) and PCOS with gingivitis (PCOS+, n = 24). Periodontal parameters, proinflammatory regulators (NFκB p65, JNK), NLRP3 components (NLRP3, ASC, procaspase-1, caspase-1) and oxidative stress markers (superoxide, <i>NRF2</i>, <i>GCLC</i> and <i>GSR</i>) were determined. The PCOS+ group presented elevated values for bleeding on probing (BOP) and plaque and calculus indices, both of which were associated with increased protein levels of NFκB p65 and JNK, thus indicating NLRP3 inflammasome priming. Higher protein levels of NLRP3, ASC, procaspase-1 and caspase-1 in the PCOS+ group confirmed that priming had occurred, suggesting an engagement in assembly. When potential assembly signals of inflammasome were evaluated, the patients with PCOS generally presented enhanced total superoxide and an impaired antioxidant response (<i>NRF2, GCLC</i> and <i>GSR</i>). Moreover, BOP was independently associated with JNK, ASC and procaspase-1. These findings suggest that gingival inflammation modulates the innate immune response in leukocytes of women with PCOS via the NLRP3 inflammasome pathway, which is regulated by proinflammatory factors and oxidative damage.
Authors
- Meylin Fernández-Reyes (ORCID: https://orcid.org/0000-0001-6311-8864)
- Jonathan Hermenejildo (ORCID: https://orcid.org/0000-0001-8954-6621)
- Carlos Morillas (ORCID: https://orcid.org/0000-0002-3745-4423)
- Francisco Javier Silvestre Donat (ORCID: https://orcid.org/0000-0001-7858-7735)
- Zaida Abad‐Jiménez (ORCID: https://orcid.org/0000-0001-6258-4724)
- Sandra López‐Domènech (ORCID: https://orcid.org/0000-0003-2067-9308)
- Milagros Rocha (ORCID: https://orcid.org/0000-0003-2923-6546)
- Cecilia Fabiana Márquez‐Arrico (ORCID: https://orcid.org/0000-0002-0185-6180)
- Javier Silvestre‐Rangil (ORCID: https://orcid.org/0000-0003-4356-5063)
- Laura Perea‐Galera (ORCID: https://orcid.org/0009-0001-3719-3614)
- Víctor M. Víctor
- María Pelechá-Salvador (ORCID: https://orcid.org/0000-0002-2141-6422)
Institutions
- Universitat de València (ES)
- Instituto de Salud Carlos III (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Universitario Doctor Peset (ES)
- INCLIVA Health Research Institute (ES)
Publication Details
- Journal
- Antioxidants
- Published
- 2025-04-24
- DOI
- https://doi.org/10.3390/antiox14050507
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Generalitat Valenciana
- Universitat de València
- Ministerio de Ciencia e Innovación
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
- HORIZON EUROPE Framework Programme
- Instituto de Salud Carlos III
- European Regional Development Fund